Table 3.
Regimen | No. of patients | % |
---|---|---|
Taxane/Cisplatin | 191 | 47.5 |
Taxane/Cisplatin/5-FU | 94 | 23.4 |
Irinotecan/5-FU | 9 | 2.2 |
Oxaliplatin/5-FU | 52 | 12.9 |
5-FU (oral or infusional fluoropyrimidines)/Cisplatin | 21 | 5.2 |
Oral fluoropyrimidine | 35 | 8.7 |
Total | 402 | 100.0 |